The Tuberculosis Drug Accelerator at year 10: what have we learned?

Nat Med. 2021 Aug;27(8):1333-1337. doi: 10.1038/s41591-021-01442-2.


The Tuberculosis Drug Accelerator, an experiment designed to facilitate collaboration in TB drug discovery by breaking down barriers among competing labs and institutions, has reached the 10-year landmark. We review the consortium’s achievements, advantages and limitations and advocate for application of similar models to other diseases.

MeSH terms

  • Antitubercular Agents / chemistry
  • Antitubercular Agents / therapeutic use*
  • Drug Design*
  • Humans
  • Learning
  • Time Factors
  • Tuberculosis / drug therapy*


  • Antitubercular Agents